4afj
From Proteopedia
(Difference between revisions)
m (Protected "4afj" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 4afj is ON HOLD until | + | The entry 4afj is ON HOLD until Paper Publication |
Authors: Gentile, G., Merlo, G., Pozzan, A., Bernasconi, G., Bax, B., Bamborough, P., Bridges, A., Carter, P., Neu, M., Yao, G., Brough, C., Cutler, G., Coffin, A., Belyanskaya, S. | Authors: Gentile, G., Merlo, G., Pozzan, A., Bernasconi, G., Bax, B., Bamborough, P., Bridges, A., Carter, P., Neu, M., Yao, G., Brough, C., Cutler, G., Coffin, A., Belyanskaya, S. | ||
Description: 5-aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors | Description: 5-aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors | ||
Revision as of 06:57, 1 February 2012
Unreleased structure
The entry 4afj is ON HOLD until Paper Publication
Authors: Gentile, G., Merlo, G., Pozzan, A., Bernasconi, G., Bax, B., Bamborough, P., Bridges, A., Carter, P., Neu, M., Yao, G., Brough, C., Cutler, G., Coffin, A., Belyanskaya, S.
Description: 5-aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors
